Prediction: This Will Be Pfizer's Next Big Move

One market in particular is too lucrative for it to miss out on any longer.Despite its impressive performance in 2020 and 2021, it's no secret that Pfizer (PFE 3.39%) is in the process of reinventing itself. Without much of the windfall from its coronavirus products propping up the top line, it may be years until revenue can top its recent peak.But that just means the company has an incentive to make big plays and take big risks to delight its shareholders. On that front, here's my prediction for what its n ...